Skip to main content
OpenTrials

Clinical trial condition

Treatment-resistant Schizophrenia

Explore clinical trials studying Treatment-resistant Schizophrenia. Study availability and eligibility vary by location and protocol.

11 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Treatment-resistant Schizophrenia trial results

Recruiting

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

NCT07184619

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, +2 more
Locations
  • UCLA DGSOM, UCLA Health, UCLA Semel Institute Los Angeles, California, United States
  • University of Miami, Miller School of Medicine; Jackson Behavioral Health Hospital Miami, Florida, United States
  • Grady Behavioral Health Center, -Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine Atlanta, Georgia, United States
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

NCT01431326

Conditions
Adenoviridae Infections, Adenovirus, Adrenal Gland Diseases, +162 more
Locations
  • Alaska Native Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California at San Diego Medical Center La Jolla, California, United States
  • Axis Clinical Trials Los Angeles, California, United States
View all 52 locations
View Trial Details

Related conditions